Israeli hospital claims may have found cure for COVID-19

Preliminary testing shows that 29 out of 30 virus patients in serious condition that were administered the drug, dubbed EXO-CD24, once a day made a full recovery within five days; similar treatment announced by Hadassah Medical Center
An Israeli hospital claims may have a cure for COVID-19, according to a report by KAN News.
  • Follow Ynetnews on Facebook and Twitter

  • Researchers at Tel Aviv's Ichilov Hospital on Thursday announced it has seen positive results in preliminary trials for a cure for COVID-19.
    2 View gallery
    מחלקת טיפול נמרץ קורונה בבית החולים איכילוב
    מחלקת טיפול נמרץ קורונה בבית החולים איכילוב
    A coronavirus ward at the Ichilov Hospital in Tel Aviv
    (Photo: TPS)
    Professor Nadir Arber from the Integrated Cancer Prevention Center at the hospital tested a medication he has been developing on patients in moderate and serious condition suffering from the virus with a 95% positive result.
    Arber says the medicine, named EXO-CD24, is inexpensive and effective and must be given once daily for five days.
    Of the 30 patients that were given the drug, 29 showed a marked improvement within two days and were released from the hospital three to five days later.
    One patient also recovered but her recovery took a few days longer, the hospital said.
    2 View gallery
    פרופ' נדיר ארבר מבית החולים איכילוב
    פרופ' נדיר ארבר מבית החולים איכילוב
    Professor Nadir Arber
    (Photo: Yuval Chen)
    After such positive results, the hospital appealed to the Health Ministry's Helsinki Committee, to request to extend the trial to more patients.
    The Hadassah Medical Center in Jerusalem also reported on a possible cure.
    The hospital administered to 21 patients in critical condition who suffered from underlying conditions a drug called Allocetra. According to the doctors, 19 patients recovered within six days and were released from the hospital on average after eight days.
    The drug was developed by Professor Dror Mevorach Director of Research Center for Rheumatology and Internal Medicine, to deal with overactive immune systems that cause secretion of cytokines.
    First published: 20:55, 02.04.21
    The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.